Novel biomarkers for subtle myocardial involvement in type I diabetes mellitus

Conclusion CT-1 has proven to be a diagnostic superiority in LV systolic dysfunction whilst BNP continues to prove every day through our study and through many others that it is the chief marker of diastolic dysfunction and HFpEF. This potential accuracy and the increasing availability of BNP in the outpatient setting make it clear that it should be used as a screening test for diabetic patients.
Source: Cardiovascular Endocrinology - Category: Cardiology Tags: Original Articles Source Type: research